Free Trial

Axiom Investors LLC DE Makes New $4.46 Million Investment in Integer Holdings Corporation $ITGR

Integer logo with Medical background

Key Points

  • Axiom Investors LLC DE has acquired a new stake in Integer Holdings Corporation, purchasing 37,772 shares valued at approximately $4,457,000 during the first quarter.
  • Several other hedge funds have also significantly increased their positions in Integer, with Millennium Management LLC growing its stake by 2,408.8% and GAMMA Investing LLC increasing its stake by 8,697.6% within the same period.
  • Integer Holdings Corporation recently reported earnings of $1.55 per share, slightly missing analysts' expectations, but its quarterly revenue increased by 11.4% year-over-year, leading to a positive outlook for FY 2025.
  • MarketBeat previews top five stocks to own in November.

Axiom Investors LLC DE bought a new position in shares of Integer Holdings Corporation (NYSE:ITGR - Free Report) during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 37,772 shares of the medical equipment provider's stock, valued at approximately $4,457,000. Axiom Investors LLC DE owned about 0.11% of Integer as of its most recent filing with the Securities & Exchange Commission.

Other large investors also recently made changes to their positions in the company. Opal Wealth Advisors LLC bought a new stake in shares of Integer during the first quarter worth $28,000. AdvisorNet Financial Inc bought a new stake in shares of Integer during the first quarter worth $28,000. SVB Wealth LLC bought a new stake in shares of Integer during the first quarter worth $35,000. Bessemer Group Inc. grew its holdings in shares of Integer by 73.1% during the first quarter. Bessemer Group Inc. now owns 296 shares of the medical equipment provider's stock worth $35,000 after purchasing an additional 125 shares during the last quarter. Finally, Headlands Technologies LLC grew its holdings in shares of Integer by 1,234.8% during the first quarter. Headlands Technologies LLC now owns 1,228 shares of the medical equipment provider's stock worth $145,000 after purchasing an additional 1,136 shares during the last quarter. Institutional investors own 99.29% of the company's stock.

Analysts Set New Price Targets

Several equities analysts have recently issued reports on the company. Citigroup raised Integer from a "hold" rating to a "strong-buy" rating and upped their price target for the company from $133.00 to $140.00 in a research note on Thursday, May 22nd. Raymond James Financial cut their price target on Integer from $150.00 to $143.00 and set an "outperform" rating on the stock in a research note on Friday, July 25th. Wells Fargo & Company cut their price target on Integer from $152.00 to $132.00 and set an "overweight" rating on the stock in a research note on Friday, July 25th. Truist Financial cut their price target on Integer from $145.00 to $137.00 and set a "buy" rating on the stock in a research note on Friday, July 25th. Finally, Wall Street Zen raised Integer from a "hold" rating to a "buy" rating in a research note on Saturday, August 30th. One analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating and one has given a Hold rating to the company's stock. According to data from MarketBeat, Integer currently has an average rating of "Buy" and an average target price of $140.25.

Check Out Our Latest Stock Analysis on Integer

Integer Trading Down 2.6%

NYSE:ITGR traded down $2.70 during mid-day trading on Friday, hitting $101.53. The company had a trading volume of 396,487 shares, compared to its average volume of 279,643. Integer Holdings Corporation has a fifty-two week low of $100.89 and a fifty-two week high of $146.36. The business's fifty day moving average is $109.53 and its two-hundred day moving average is $115.96. The company has a debt-to-equity ratio of 0.72, a quick ratio of 2.18 and a current ratio of 3.41. The firm has a market cap of $3.56 billion, a P/E ratio of 44.73, a P/E/G ratio of 0.82 and a beta of 1.03.

Integer (NYSE:ITGR - Get Free Report) last released its earnings results on Thursday, July 24th. The medical equipment provider reported $1.55 earnings per share for the quarter, missing the consensus estimate of $1.57 by ($0.02). Integer had a net margin of 4.61% and a return on equity of 12.27%. The company had revenue of $476.00 million during the quarter, compared to analyst estimates of $464.37 million. During the same period in the previous year, the company posted $1.30 EPS. The company's quarterly revenue was up 11.4% compared to the same quarter last year. Integer has set its FY 2025 guidance at 6.250-6.510 EPS. As a group, research analysts expect that Integer Holdings Corporation will post 6.01 earnings per share for the current year.

About Integer

(Free Report)

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.

Recommended Stories

Institutional Ownership by Quarter for Integer (NYSE:ITGR)

Should You Invest $1,000 in Integer Right Now?

Before you consider Integer, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Integer wasn't on the list.

While Integer currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Stocks to Own: Fall 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.